These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9180125)
1. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. Morris SD; Yellon DM J Am Coll Cardiol; 1997 Jun; 29(7):1599-606. PubMed ID: 9180125 [TBL] [Abstract][Full Text] [Related]
2. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation. Miki T; Miura T; Ura N; Ogawa T; Suzuki K; Shimamoto K; Iimura O J Am Coll Cardiol; 1996 Nov; 28(6):1616-22. PubMed ID: 8917279 [TBL] [Abstract][Full Text] [Related]
3. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart. Anning PB; Grocott-Mason RM; Lewis MJ Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of beta-adrenergic receptor upregulation induced by ACE inhibition in cultured neonatal rat cardiac myocytes: roles of bradykinin and protein kinase C. Yonemochi H; Yasunaga S; Teshima Y; Iwao T; Akiyoshi K; Nakagawa M; Saikawa T; Ito M Circulation; 1998 Jun; 97(22):2268-73. PubMed ID: 9631877 [TBL] [Abstract][Full Text] [Related]
5. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries. Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632 [TBL] [Abstract][Full Text] [Related]
6. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits. Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422 [TBL] [Abstract][Full Text] [Related]
7. Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism. Ebrahim Z; Baxter GF; Yellon DM Cardiovasc Drugs Ther; 2004 Mar; 18(2):127-34. PubMed ID: 15162074 [TBL] [Abstract][Full Text] [Related]
8. Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria. Tesfamariam B; Allen GT; Powell JR Eur J Pharmacol; 1995 Jul; 281(1):17-20. PubMed ID: 8566111 [TBL] [Abstract][Full Text] [Related]
9. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Sato M; Engelman RM; Otani H; Maulik N; Rousou JA; Flack JE; Deaton DW; Das DK Circulation; 2000 Nov; 102(19 Suppl 3):III346-51. PubMed ID: 11082412 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium. Rump LC; Berlit T; Schwertfeger E; Beyersdorf F; Schollmeyer P; Bohmann C J Hypertens; 1997 Nov; 15(11):1263-70. PubMed ID: 9383175 [TBL] [Abstract][Full Text] [Related]
12. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat. Sulpizio AC; Pullen MA; Edwards RM; Brooks DP J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834 [TBL] [Abstract][Full Text] [Related]
13. Blood pressure responses to acute or chronic captopril in mice with disruption of bradykinin B2-receptor gene. Emanueli C; Angioni GR; Anania V; Spissu A; Madeddu P J Hypertens; 1997 Dec; 15(12 Pt 2):1701-6. PubMed ID: 9488225 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors. Yayama K; Sugiyama K; Miyagi R; Okamoto H Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864 [TBL] [Abstract][Full Text] [Related]
15. Delayed preconditioning via Angiotensin-converting enzyme inhibition: pros and cons from an experimental study. Marktanner R; Nacke P; Feindt P; Hohlfeld T; Schipke JD; Gams E Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):787-92. PubMed ID: 16922807 [TBL] [Abstract][Full Text] [Related]
16. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart. Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319 [TBL] [Abstract][Full Text] [Related]